Synchrony Medical
Airway Clearance System for Home Use
Company Overview
Snapshot
Founded in October 2020 by Moshe Ashkenazi, Ori Efrati, and Gil Sokol, Synchrony Medical operates with 1–10 employees. The company has raised $6.8M across three funding rounds, with Edge Medical Ventures leading a February 2026 round. Synchrony Medical secured FDA approval for its LibAirty airway clearance technology in July 2025.
Business overview
Synchrony Medical is a clinical-stage medical device company specializing in respiratory care. The company develops LibAirty, a next-generation airway clearance system designed for home use. This technology aims to help patients with chronic lung diseases, such as chronic obstructive pulmonary disease and cystic fibrosis, maintain clear lungs through short and effective daily treatments. Synchrony Medical operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Digital Healthcare, serving patients and healthcare providers.
Strategic signal
In October 2025, Synchrony Medical launched its LibAirty Airway Clearance System in the US, marking a significant step in making its FDA-approved technology commercially available. This launch indicates the company's transition from clinical development to market penetration, suggesting a strong growth trajectory and potential for widespread adoption in at-home respiratory care.
Company Intelligence Q&A
- What is Synchrony Medical's primary product?
- Synchrony Medical's primary product is LibAirty, a next-generation airway clearance system designed for home use to help patients with chronic lung diseases maintain clear lungs.
- When did Synchrony Medical launch its LibAirty system in the US?
- Synchrony Medical launched its LibAirty Airway Clearance System in the US in October 2025, aiming to establish a new standard for at-home respiratory care.
- Has Synchrony Medical's technology received regulatory approval?
- Yes, Synchrony Medical's technology for airway clearance received FDA approval in July 2025, paving the way for its commercial launch.
- What was a recent funding event for Synchrony Medical?
- In February 2026, Synchrony Medical secured funding from Edge Medical Ventures to fuel the commercial expansion of its at-home airway clearance device for chronic respiratory disease.
- What was the outcome of a clinical study for LibAirty?
- A clinical study conducted at the Medical University of South Carolina in October 2023 found Synchrony Medical's LibAirty Airway Clearance System to be highly effective for chronic lung disease patients.